Zacks Research Has Bearish Forecast for Amgen Q2 Earnings

Amgen Inc. (NASDAQ:AMGN – Free Report) – Equities researchers at Zacks Research lowered their Q2 2025 EPS estimates for Amgen in a report issued on Thursday, May 22nd. Zacks Research analyst R. Department now expects that the medical research company will post earnings of $5.20 per share for the quarter, down from their prior estimate […]

Leave a Reply

Your email address will not be published.

Previous post Zacks Research Issues Pessimistic Estimate for BHC Earnings
Next post Research Analysts Set Expectations for BIO Q2 Earnings